Pulmonary Tuberculosis: Developing Drugs for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 14, 2022
December 19, 2022
8b46de55-ddca-4887-a2ad-5d46be5633aa
Related Documents
Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention
Guidance DocumentOctober 27, 2022Center for Drug Evaluation and Research
Statistical Approaches to Establishing Bioequivalence
Guidance DocumentDecember 2, 2022Center for Drug Evaluation and Research
Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 13, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox